Clinical Trials Browser

Phase 2 × Small Cell Lung Cancer Extensive Stage × apatinib × Clear all

NCT06429696 2025-05-28

PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer

Phase 2 Recruiting

Small Cell Lung Cancer Extensive Stage